Dr. Farzin’s research uses the science and technologies in the field of pathogen detection and pathogenesis of sepsis for early diagnosis and timely management of neonatal sepsis in resource-limited settings.
Neonatal infections account for nearly one million deaths worldwide every year with majority occurring in resource-limited settings. Extreme difficulty in clinical diagnosis of neonatal sepsis and limited access to appropriate resources contribute greatly to these preventable deaths.
With a joint position at the school of medicine and the school of public health, Dr. Farzin is interested in constructing practical solutions for improving the health of neonates in developing settings based on the rapidly advancing knowledge in neonatal medicine and infectious diseases.
Currently, she is collaborating with colleagues from other disciplines including the biomedical engineering department at Johns Hopkins University and other international institutions to validate innovative diagnostic solutions for rapid and accurate detection of neonatal sepsis. Her goal is to translate such markers into point-of-care devices, which can be used in resource-limited settings.